Sean A. McCarthy - Jun 16, 2021 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
President and CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Stock symbol
CTMX
Transactions as of
Jun 16, 2021
Transactions value $
-$704,470
Form type
4
Date filed
6/21/2021, 03:51 PM
Previous filing
Jun 16, 2021
Next filing
Aug 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale -$704K -100K -51.78% $7.04 93.1K Jun 16, 2021 See footnote F1, F2, F3
holding CTMX Common Stock 7.85K Jun 16, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
F3 This transaction was executed in multiple trades in prices ranging from $6.88 to $7.135, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.